Age Related Macular Degeneration (AMD) research hub

ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

Development of Novel Clinical Endpoints in Intermediate AMD

This study looks at how to best measure changes in intermediate Age-related Macular Degeneration (AMD). It aims to find new ways to track the condition's progression, understand how it affects vision, and identify risks for it getting worse. There are no treatments involved.

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

This study is looking into new treatments, pozelimab and cemdisiran, for Geographic Atrophy (GA), an advanced form of Age-related Macular Degeneration (AMD). It compares these new drugs, alone or together, against a placebo to see if they can slow down vision loss.